Pre- and post-diagnostic beta-blocker use and lung cancer survival: a population-based cohort study

被引：0
|
作者：
Weberpals, Janick [1 ]
Jansen, Lina [1 ]
Haefeli, Walter E. [2 ]
Hoffmeister, Michael [1 ]
Wolkewitz, Martin [3 ]
van Herk-Sukel, Myrthe P. P. [4 ]
Vissers, Pauline A. J. [5 ]
Brenner, Hermann [1 ,6 ]
机构：
[1] German Canc Res Ctr, Heidelberg, Germany
[2] Univ Hosp Heidelberg, Heidelberg, Germany
[3] Univ Freiburg, Freiburg, Germany
[4] PHARMO Inst Drug Outcomes Res, Utrecht, Netherlands
[5] Netherlands Comprehens Canc Org, Utrecht, Netherlands
[6] German Canc Res Ctr, Natl Ctr Tumor Dis NCT, Heidelberg, Germany
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2017年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
445
引用
收藏
页码：269 / 270
页数：2
相关论文
共 50 条
  • [1] Pre- and post-diagnostic β-blocker use and lung cancer survival: A population-based cohort study
    Weberpals, Janick
    Jansen, Lina
    Haefeli, Walter E.
    Hoffmeister, Michael
    Wolkewitz, Martin
    van Herk-Sukel, Myrthe P. P.
    Vissers, Pauline A. J.
    Brenner, Hermann
    SCIENTIFIC REPORTS, 2017, 7
  • [2] Pre- and post-diagnostic β-blocker use and lung cancer survival: A population-based cohort study
    Janick Weberpals
    Lina Jansen
    Walter E. Haefeli
    Michael Hoffmeister
    Martin Wolkewitz
    Myrthe P. P. van Herk-Sukel
    Pauline A. J. Vissers
    Hermann Brenner
    Scientific Reports, 7
  • [3] Pre- and post-diagnostic beta-blocker use and prognosis after colorectal cancer: Results from a population-based study
    Jansen, Lina
    Weberpals, Janick
    Kuiper, Josephina G.
    Vissers, Pauline A. J.
    Wolkewitz, Martin
    Hoffmeister, Michael
    Brenner, Hermann
    INTERNATIONAL JOURNAL OF CANCER, 2017, 141 (01) : 62 - 71
  • [4] Post-diagnostic beta blocker use and breast cancer-specific mortality: a population-based cohort study
    Oliver William Scott
    Sandar Tin Tin
    J. Mark Elwood
    Alana Cavadino
    Laurel A. Habel
    Marion Kuper-Hommel
    Ian Campbell
    Ross Lawrenson
    Breast Cancer Research and Treatment, 2022, 193 : 225 - 235
  • [5] Post-diagnostic beta blocker use and breast cancer-specific mortality: a population-based cohort study
    Scott, Oliver William
    Tin, Sandar Tin
    Elwood, J. Mark
    Cavadino, Alana
    Habel, Laurel A.
    Kuper-Hommel, Marion
    Campbell, Ian
    Lawrenson, Ross
    BREAST CANCER RESEARCH AND TREATMENT, 2022, 193 (01) : 225 - 235
  • [6] Beta-blocker use and survival after pancreatic cancer surgery: A nationwide population-based cohort study
    Kirkegard, Jakob
    Cronin-Fenton, Deirdre
    Lund, Andrea
    Mortensen, Frank Viborg
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 (01)
  • [7] Associations between pre- and post-diagnostic use of beta-blockers and ovarian cancer survival
    Brown, Chris
    Barron, Thomas
    Bennett, Kathleen
    Sharp, Linda
    EUROPEAN JOURNAL OF CANCER CARE, 2015, 24 : 21 - 21
  • [8] Post-diagnostic antipsychotic use and cancer mortality: a population based cohort study
    Blánaid M. Hicks
    John Busby
    Ken Mills
    Francis A. O’Neil
    Stuart A. McIntosh
    Shu-Dong Zhang
    Fabio Giuseppe Liberante
    Chris R. Cardwell
    BMC Cancer, 20
  • [9] Post-diagnostic antipsychotic use and cancer mortality: a population based cohort study
    Hicks, Blanaid M.
    Busby, John
    Mills, Ken
    O'Neil, Francis A.
    McIntosh, Stuart A.
    Zhang, Shu-Dong
    Liberante, Fabio Giuseppe
    Cardwell, Chris R.
    BMC CANCER, 2020, 20 (01)
  • [10] Post-diagnostic statin use and breast cancer-specific mortality: A population-based cohort study
    Scott, Oliver W.
    TinTin, Sandar
    Harborg, Sixten
    Kuper-Hommel, Marion
    Lawrenson, Ross
    Elwood, Mark
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 620 - 620
12345